Navigation Links
Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or 'Off-The-Shelf' Stem Cell Treatment for Heart Attacks
Date:9/5/2011

MELBOURNE, Australia, Sept. 5, 2011 /PRNewswire/ -- Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor(TM) is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

The placebo-controlled Phase 2 trial, AMICI (Allogeneic Mesenchymal precursor cell Infusion in myoCardial Infarction), is approved under Europe's voluntary harmonization procedure and will initially recruit patients at multiple European sites, including in the United Kingdom, The Netherlands and Belgium. Trial recruitment is subsequently expected to involve sites in additional European nations, Australia, and the United States. The primary endpoint of the study will be safety and efficacy at six months in heart attack patients who will receive either Revascor(TM) at one of two doses or placebo. Durability of effect will additionally be monitored for up to 36 months.

Heart attacks remain the biggest killer of people in the industrialized world. Every year, over 1.7 million people have a heart attack in Europe, and over 1.1 million in the United States. Most of these patients undergo an early angioplasty of the blocked artery accompanied by implantation of a metal stent to keep the artery open long-term. However, a significant number of the surviving patients subsequently become disabled with heart failure.

Revascor(TM) is injected by a simple intracoronary infusion at the same time as the
'/>"/>

SOURCE Mesoblast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lupin Receives Final Approval to Market Generic Ultram® ER
2. Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants
3. Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances
4. Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes
5. Simceres Iremod Receives SFDA New Drug Approval
6. PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
7. WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU
8. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
9. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
10. Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients
11. INNOPHARMA Receives FDA Approval of Generic Levetiracetam Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Ill., April 19, 2011 Sysmex, a global ... systems technology, announced today an amended distributorship agreement ... automatically renews for up to four successive one-year ... including the Sysmex pocH-100 i™ , Sysmex KX-21N™, ...
... Premier Research Group Limited announces the re-branding of ... Research Company. With the continued growth in clinical development ... the medical device industry, Premier Research recognises this sector ... D-TARGET was founded in 1997 and acquired ...
Cached Medicine Technology:Sysmex America Signs Distributorship Agreement With LABSCO 2Premier Research Re-brands its Medical Device Business Unit to D-TARGET 2
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting ... auto insurance policy . , Some types of vehicles cannot ... the newly released blog post to see if their vehicle qualifies ... vehicles are some of the cars that cannot be covered by ...
(Date:1/22/2015)... 22, 2015 Step into a macabre ... Science Museum of Virginia. Wicked Plants, the Museum’s latest ... unearths 75 poisonous, carnivorous and diabolical plants inside of ... to uncover the biochemical, physical and neurological processes between ...
(Date:12/26/2014)... The US represents the largest market for CRC across the ... that sales of branded therapies were $2.23 billion. The US ... of the disease, high drug treatment rate, and higher drug ... of CRC therapies over the forecast period will be driven ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... researchers have identified the first biomarker of graft-versus-host disease ... blood test that should solve a treatment dilemma facing ... marrow transplants. The biomarker also makes it possible to ... graft-versus-host disease, or GVHD. GVHD is a serious, ...
... continue climbing to exhaustion may be the only determinant of ... the University of Granada, the objective of which is to ... of sport, shows this to be the case. ... fat percentage and grip strength. Furthermore, existing research was based ...
... CT, ultrasound imaging and MRI, doctors have long been able ... patient,s body, and now a Texas A&M University mathematician is ... , The professor, Peter Kuchment, a leading researcher in mathematical ... process for detecting cancer and many other diseases. , When ...
... Researchers ... working to reduce the radiation exposure associated with CT imaging. A study featured on the ... cancer from CT imaging. , ... Loma Linda, CA (Vocus) January 7, 2010 -- Researchers from the department of radiology and ...
... ... ... College of American Pathologists (CAP) released the new CAP electronic Cancer Checklists (CAP eCC)—the XML ... enhance and advance cancer reporting., , , , ,The latest CAP eCC release contains all ...
... ... , ... 8, 2010 -- After more than 20 years with very little innovation, the world of ... tool for cast removal. , , , , ,With an operating sound level just above ...
Cached Medicine News:Health News:Blood test could improve graft-versus-host disease treatment 2Health News:Blood test could improve graft-versus-host disease treatment 3Health News:How high can a climber go? 2Health News:Texas A&M prof working on new ways to see through the human body 2Health News:New Low Dose CT Protocols for Stone Detection may Hold Key to Reducing Cancer Risk from Radiation 2Health News:New Low Dose CT Protocols for Stone Detection may Hold Key to Reducing Cancer Risk from Radiation 3Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 2Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 3Health News:College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC) 4Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: